In the interview Michael Kidd
describes the reasons for launching this exciting new journal; primarily to
create a dedicated, open access home for case reports – articles which have often been overlooked by
Professor Kidd extols the importance of case
reports for communicating new and unusual clinical findings, including early
reports of new and emerging diseases such as SARS and bird flu, and reports of
rare side-effects of new medications. In
due course, all case reports published in the journal will be aggregated into a
structured case reports database. The database will also draw content from other
sources, making it possible to search for example, for patterns of drug
reactions, hopefully driving future research.
As case report
articles are relatively short and simple to prepare, this new journal also
provides a great opportunity for new authors to publish for the first time,
sharing important lessons learnt from their clinical work.